Literature DB >> 17898020

Inspiratory flow rates at different levels of resistance in elderly COPD patients.

W Janssens1, P VandenBrande, E Hardeman, E De Langhe, T Philps, T Troosters, M Decramer.   

Abstract

Dry powder inhalers (DPIs) are increasingly replacing metered dose inhalers in elderly chronic obstructive pulmonary disease (COPD) patients. However, most DPIs are dependent on inspiratory flow, which is compromised by the ageing process itself. Using the in-check dial method, the present study compared peak inspiratory flow (PIF) rates in 26 elderly COPD patients and 14 matched control subjects, at a pre-set resistance level of the Aeroliser, Diskus and Turbuhaler inhalers. It was found that the PIF measured by the in-check method positively correlated with the PIF derived from spirometry, forced vital capacity and maximal inspiratory pressure, while a negative, but significant, correlation was observed with age. PIF derived from spirometry and age were independent variables which determined PIF across the device, whereas the presence or absence of COPD was not related. When comparing elderly COPD patients with matched elderly controls no difference could be found in PIF at the different resistances. However, an important number of patients did not reach the recommended flow rate, especially when using the Turbuhaler (30%). In conclusion, the present study demonstrates that, in elderly patients, the ability to generate sufficient inspiratory flow across a dry powder inhaler is compromised, irrespective of the presence of chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898020     DOI: 10.1183/09031936.00024807

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  58 in total

1.  Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?

Authors:  Patricia Tang; Philip Chi Lip Kwok; Zhenbo Tong; Runyu Yang; Judy Agnes Raper; Hak-Kim Chan
Journal:  Pharm Res       Date:  2012-02-11       Impact factor: 4.200

2.  Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation.

Authors:  Gulshan Sharma; Donald A Mahler; Valerie M Mayorga; Kathleen L Deering; Oing Harshaw; Vaidyanathan Ganapathy
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-15

3.  Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.

Authors:  Robert A Wise; Russell A Acevedo; Antonio R Anzueto; Nicola A Hanania; Fernando J Martinez; Jill A Ohar; Donald P Tashkin
Journal:  Chronic Obstr Pulm Dis       Date:  2016-11-15

4.  Personalization of Device Therapy - Prime Time for Peak Inspiratory Flow Rate.

Authors:  Chee H Loh; Jill A Ohar
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-14

Review 5.  Managing older patients with coexistent asthma and chronic obstructive pulmonary disease: diagnostic and therapeutic challenges.

Authors:  Vanessa M McDonald; Isabel Higgins; Peter G Gibson
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

Review 6.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Authors:  Donald P Tashkin; Leonardo M Fabbri
Journal:  Respir Res       Date:  2010-10-29

7.  Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: age and gender rather than severity matters.

Authors:  L Pekka Malmberg; Paula Rytilä; Pertti Happonen; Tari Haahtela
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-08-09

Review 8.  Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults.

Authors:  Shoab A Nazir; Marcia L Erbland
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

Authors:  Gabriele Nicolini; Nicola Scichilone; Andrea Bizzi; Alberto Papi; Leonardo M Fabbri
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

10.  Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options.

Authors:  Nicola Scichilone; Adele Contino; Giovanni Battista Figlioli; Giuseppe Paglino; Vincenzo Bellia
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.